“FDA Overhaul Overdue”…
Outside EditorialsDr. Miller precedes his list of desirable qualities of a new FDA commissioner with this entry:
The FDA is desperately in need of renewal: It is dysfunctional, suffering from cultural, organizational and management problems that have been exacerbated by congressional mandates and meddling. As a result, drug development by major U.S.-based drug companies is in dire straits, with costs up and regulatory approvals down.
Read the rest of Dr. Miller’s piece here.
Read more from Outside Editorials...
"Mr. President-elect, strengthen fight against cancer" by Lance Armstrong »
« Group Therapy: How poorly designed trials for cancer drugs are hurting patients
Latest Press
- “The FDA is Killing Crohn’s Patients” by Gideon J. SoferA young man's story of his fight for life against Crohn's disease
- “Mr. President-elect, strengthen fight against cancer” by Lance ArmstrongA recent commentary piece by Lance Armstrong, cycling champion and founder of LiveStrong
- “FDA Overhaul Overdue” by Henry MillerDr. Miller, who headed the Food and Drug Administration's Office of Biotechnology from 1989 to 1993, calls for reform
Blog
- Welcome, from the Director of Accelerate ProgressA welcome and introduction to our organization and our website, dedicated to accelerating progress for patients fighting life-threatening illnesses
- 2008 Year in ReviewA reflection on the milestones reached by Accelerate Progress in 2008
- A word on Leukemia and progress from Dr. Emil J. FreireichA brief history of our progress against Leukemia and a warning about the effects of regulation on patients, from a leader in his field
